Val operational review today15 Dec 2023 07:05
VAL201 remains subject to the Letter of Intent ("LoI") with TheoremRx Inc ("TheoremRx"), and we noted with interest the announcement by EUDA Health Holdings Inc in relation to its proposed merger with TheoremRx. We maintain regular lines of communications with the TheoremRx team to monitor progress on their continuing efforts to secure financing, which will enable the VAL201 sub-license to complete. The sub-license contains provisions for upfront and early-stage milestone payment and will release the immediate payment for work already conducted under the previously announced service agreement as well as a commitment for future service provision.